Home
GlaxoSmithKline and Vir Biotechnology Announced U.S. Gov’t Contracts to Purchase $1B of Sotrovimab for COVID-19

GlaxoSmithKline and Vir Biotechnology Announced U.S. Gov’t Contracts to Purchase $1B of Sotrovimab for COVID-19

Today’s Highlights November 17, 2021

GlaxoSmithKline and Vir Biotechnology Announces US Gov't Contracts to Purchase Sotrovimab for COVID-19
GlaxoSmithKline plc (GSK) and Vir Biotechnology (This content is for paid subscribers.

Please click here to subscribe or here to log in.
Today’s Highlights
, ,
November 17, 2021

Other Articles